Protein detail
FGFR3
Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
Entry name FGFR3 | UniProt ID | EVMP score 0.47 |
Frequency 11 | Transmembrane count 1 | Protein classification Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteins |
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)
Protein Class
Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteins
Protein Function
- Cancer-related genes:Mutational cancer driver genes
- Predicted intracellular proteins
- Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system
- ENZYME proteins:Transferases
- Cancer-related genes:Mutated cancer genes
- CD markers
- RAS pathway related proteins
- Enzymes
- Cancer-related genes:Candidate cancer biomarkers
- Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues
- Human disease related genes:Cancers:Cancers of the urinary system
- Human disease related genes:Congenital malformations:Congenital malformations of skin
- Human disease related genes:Congenital malformations:Other congenital malformations
- Kinases:Tyr protein kinases
- Disease related genes
- Human disease related genes:Cancers:Cancers of male genital organs
- Predicted secreted proteins
- FDA approved drug targets:Small molecule drugs
Transmembrane
376..396; Helical
Transmembrane Count
1
Ensembl
Entrez Gene Symbol
Gene Synonym
ACHCD333CEK2JTK4
Gene Description
Fibroblast growth factor receptor 3
Chromosome
4
Position
1793293-1808872
Frequency
11
EVMP Score
0.47
Fluorescence & Localization
Cell SpecificAstrocytesSingle-Nuclei Brain SpecificpericyteBlood Cell Specificmemory B-cellBlood Lineage SpecificB-cells
Function & Pathway
Protein Function
- Cancer-related genes:Mutational cancer driver genes
- Predicted intracellular proteins
- Human disease related genes:Congenital malformations:Congenital malformations of the musculoskeletal system
- ENZYME proteins:Transferases
- Cancer-related genes:Mutated cancer genes
- CD markers
- RAS pathway related proteins
- Enzymes
- Cancer-related genes:Candidate cancer biomarkers
- Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues
- Human disease related genes:Cancers:Cancers of the urinary system
- Human disease related genes:Congenital malformations:Congenital malformations of skin
- Human disease related genes:Congenital malformations:Other congenital malformations
- Kinases:Tyr protein kinases
- Disease related genes
- Human disease related genes:Cancers:Cancers of male genital organs
- Predicted secreted proteins
- FDA approved drug targets:Small molecule drugs
Cellular Component
Molecular Function
Biological Process
KEGG
- hsa01521 EGFR tyrosine kinase inhibitor resistance
- KEGG:hsa04010 MAPK signaling pathway
- KEGG:hsa04014 Ras signaling pathway
- KEGG:hsa04015 Rap1 signaling pathway
- KEGG:hsa04020 Calcium signaling pathway
- KEGG:hsa04144 Endocytosis
- KEGG:hsa04151 PI3K-Akt signaling pathway
- KEGG:hsa04550 Signaling pathways regulating pluripotency of stem cells
- KEGG:hsa04810 Regulation of actin cytoskeleton
- KEGG:hsa05200 Pathways in cancer
- KEGG:hsa05206 MicroRNAs in cancer
- KEGG:hsa05219 Bladder cancer
- KEGG:hsa05230 Central carbon metabolism in cancer
Reactome
- R-hsa-2219530 constitutive signaling by aberrant pi3k in cancer
- R-hsa-5663202 diseases of signal transduction by growth factor receptors and second messengers
- R-hsa-5654708 downstream signaling of activated fgfr3
- R-hsa-190371 fgfr3b ligand binding and activation
- R-hsa-190239 fgfr3 ligand binding and activation
- R-hsa-5654706 frs mediated fgfr3 signaling
- R-hsa-74751 insulin receptor signalling cascade
- R-hsa-9006925 intracellular signaling by second messengers
- R-hsa-112399 irs mediated signalling
- R-hsa-5684996 mapk1 mapk3 signaling
- R-hsa-5683057 mapk family signaling cascades
- R-hsa-5654732 negative regulation of fgfr3 signaling
- R-hsa-199418 negative regulation of the pi3k akt network
- R-hsa-2219528 pi3k akt signaling in cancer
- R-hsa-5654710 pi 3k cascade fgfr3
- R-hsa-5654704 shc mediated cascade fgfr3
- R-hsa-190236 signaling by fgfr
- R-hsa-5654741 signaling by fgfr3
- R-hsa-1226099 signaling by fgfr in disease
- R-hsa-74752 signaling by insulin receptor
- R-hsa-9006934 signaling by receptor tyrosine kinases
- R-hsa-2404192 signaling by type 1 insulin like growth factor 1 receptor igf1r
Mediation Categories
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation
Relations & Evidence
Enzyme-Mediated Modification
2 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| FGFR3 | FGFR1 | P11362 | Y | 599 | phosphorylation | PhosphoSite | |
| FGFR3 | IGF1R | P08069 | Y | 647 | phosphorylation | KEA | KEA:17570479 |
Ligand-Receptor Signaling
63 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| extracellular | extracellular | OmniPath | No | No | Yes | Yes | No |
| intracellular | intracellular | LOCATE | No | No | Yes | Yes | No |
| intracellular | intracellular | ComPPI | No | No | Yes | Yes | No |
| intracellular | intracellular | GO_Intercell | No | No | Yes | Yes | No |
| intracellular | intracellular | UniProt_location | No | No | Yes | Yes | No |
| intracellular | intracellular | OmniPath | No | No | Yes | Yes | No |
| cell_adhesion | cell_adhesion | Cellinker | Yes | Yes | Yes | Yes | No |
| adhesion | adhesion | OmniPath | Yes | Yes | Yes | Yes | No |
| cell_adhesion | cell_adhesion | OmniPath | Yes | Yes | Yes | Yes | No |
| transmembrane | transmembrane | UniProt_location | No | No | Yes | Yes | No |
Regulatory Interaction Network
10 records.
Protein Complex Composition
4 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| FGF1FGFR3 | P05230P22607 | 1:1 | PDB | PDB:1ry7 | ||
| FGFR3 | P22607 | 2 | PDB | PDB:2lzlPDB:8uduPDB:6pnxPDB:8udvPDB:9cd7PDB:8udt | ||
| B9D1B9D2FGFR3TMEM231 | P22607Q9BPU9Q9H6L2Q9UPM9 | 0:0:0:0 | hu.MAP | |||
| FGF23FGFR3KL | P22607Q9GZV9Q9UEF7 | 2:1:1 | PDB | PDB:7ysu |
Isolation & Detection Technology
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential UltracentrifugationSize Exclusion ChromatographyImmunoaffinity Capture | Mass Spectrometry | 1 | 38113368 |
Sequence, Structure & Domains
Sequences
Length
806
Mass
87,710
Sequence
MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCHFSVRVTDAPSSGDDEDGEDEAEDTGVDTGAPYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHRIGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSPHRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGPDGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPSSGGSRT
Alternative Products
Event=Alternative splicing; Named isoforms=4; Name=1; Synonyms=IIIc; IsoId=P22607-1; Sequence=Displayed; Name=2; Synonyms=IIIb; IsoId=P22607-2; Sequence=VSP_002988; Name=3; Synonyms=FGFR3deltaTM; IsoId=P22607-3; Sequence=VSP_002989; Name=4; IsoId=P22607-4; Sequence=VSP_040945
Alternative Sequence
311..422; Missing (in isoform 3); 311..358; TAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLP -> SWISESVEADVRLRLANVSERDGGEYLCRATNFIGVAEKAFWLSVHGPRA (in isoform 2); 654..806; GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPSSGGSRT -> LVLWGPALGDLHAGGLPVPRHPCGGALQAAEGGPPHGQARQLHTRPVHDHAGVLACRALPEAHLQAAGGGPGPCPYRDVHRRVPGPVGAFRAVLPGWPGHPQLQLLRGRLRVCPRPAAPGPTQQWGLADVKGHWSPTM (in isoform 4)
3D Structural Models
Turn
208..211; 319..321; 643..645
Helix
156..158; 220..222; 293..295; 374..398; 463..465; 469..471; 516..532; 563..568; 591..610; 620..622; 658..660; 663..668; 673..688; 700..708; 721..730; 735..737; 741..756
Beta Strand
152..154; 163..167; 172..175; 185..187; 212..215; 226..232; 235..246; 263..268; 271..273; 283..289; 302..304; 324..326; 331..333; 335..345; 348..357; 369..372; 472..477; 480..492; 495..497; 502..508; 541..545; 547..550; 552..556; 571..573; 623..625; 631..633; 646..649; 653..655
3D Structure
Electron microscopy (1); NMR spectroscopy (1); X-ray crystallography (11)
Domain & Motif Annotations
Compositional Bias
132..145; Acidic residues; 771..787; Low complexity
Domain (CC)
The second and third Ig-like domains directly interact with fibroblast growth factors (FGF) and heparan sulfate proteoglycans.
Domain (FT)
24..126; Ig-like C2-type 1; 151..244; Ig-like C2-type 2; 253..355; Ig-like C2-type 3; 472..761; Protein kinase
Region
126..153; Disordered; 765..806; Disordered
Protein Families
- Protein kinase superfamily
- Tyr protein kinase family
- Fibroblast growth factor receptor subfamily
Sequence Similarities
Belongs to the protein kinase superfamily. Tyr protein kinase family. Fibroblast growth factor receptor subfamily.
Clinical Relevance
Disease Involvement
Cancer-related genesCraniosynostosisDeafnessDisease variantDwarfismEctodermal dysplasiaFDA approved drug targetsLacrimo-auriculo-dento-digital syndrome
Related Diseases
Biomarker
Phase 1/2; Phase 2; Phase 4; Approved; Phase 1; Phase 3; Terminated
Drug Targets
FDA approved drug targets
Drugs
NINTEDANIB ESYLATENULLXL-999PD173074LINIFANIBGEFITINIBDACTOLISIBINFIGRATINIBMK-2461FUTIBATINIBCETRELIMABHMPL-453PALIFERMINDERAZANTINIBVOFATAMABTYROSINE KINASE INHIBITOR SU5402DOCETAXEL ANHYDROUSCEDIRANIBINFIGRATINIB PHOSPHATE3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONENIVOLUMABXL228FGFR INHIBITOR CPL304110ALISERTIBLY2874455PAZOPANIBBRIVANIBFEXAGRATINIBERDAFITINIBALPELISIBCISPLATINNVP-TAE684BORTEZOMIBPICTILISIBTRAPIDILTASURGRATINIBSORAFENIBIRINOTECAN HYDROCHLORIDEENMD-2076MLN-8054RABEPRAZOLEMASITINIBZOLIGRATINIBBRIVANIB ALANINATEENMD-981693U0126AZD-4547CP-547632ROGARATINIBDOVITINIBPONATINIBVARGATEFPD98059ASP5878SP-600125AEE-788DASATINIB ANHYDROUSSSR128129EPF-562271MIDOSTAURINERLOTINIBPEMIGATINIBILORASERTIBFGFR3 INHIBITOR TYRA-300PRN1371SINTILIMABRG-7444ENTRECTINIBFP-1039TRAFERMINDOVITINIB LACTATERG-1530IPATASERTIBAVUTOMETINIBANLOTINIBGUNAGRATINIBHESPERADINREGORAFENIBFGFR/CSF-1R INHIBITOR 3D185LY-2874455MEK INHIBITOR RO4987655ATEZOLIZUMABTAMATINIBCENISERTIBGEMCITABINECHEMBL:CHEMBL578061SELUMETINIBPI3K/BET INHIBITOR LY294002CP-459632ORANTINIBFGFR INHIBITOR DEBIO 1347S-49076TOZASERTIBCYC-116QUISINOSTAT
Interaction Protein
ENSG00000096384ENSG00000104824ENSG00000105401ENSG00000113578
Interaction Count
4
Interaction Dataset
intact_biogrid